SEARCH

SEARCH BY CITATION

References

  • 1
    Vorobioff J, Picabea E, Villavicencio R, et al. Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients. Hepatology 1987; 7: 64853.
  • 2
    Groszmann RJ, Bosch J, Grace N, et al. Hemodynamic events in a prospective randomized trial of propranolol vs. placebo in the prevention of the first variceal hemorrhage. Hepatology 1990; 99: 14017.
  • 3
    Sacerdoti D, Merkel C, Gatta A. Importance of the 1-month-effect of nadolol on portal pressure in predicting failure of prevention of rebleeding in cirrhosis. J Hepatol 1991; 12: 1245.
  • 4
    Feu F, Garcia-Pagan JC, Bosch J, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995; 346: 10569.
  • 5
    Villanueva C, Balanzò J, Novella MT, et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med 1996; 334: 16249.
  • 6
    Merkel C, Bolognesi M, Sacerdoti D, et al. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2000; 32: 9304.
  • 7
    Valla D, Jiron D, Poynard T, Braillon A, Lebrec D. Failure of hemodynamic measurements to predict recurrent gastrointestinal bleeding in cirrhotic patients receiving propranolol. J Hepatol 1987; 5: 1448.
  • 8
    Aracil C, Lòpez-Balaguer JM, Monfort D, et al. Hemodynamic response to beta-blockers and prediction of clinical efficacy in the primary prophylaxis of variceal bleeding in patients with cirrhosis. Hepatology 2003; 38 (Suppl. 1): 296A.
  • 9
    de Madaria E, Palazon JM, Sanchez J, et al. Monitoring of HVPG during pharmacological treatment: a comparison between two methods. J Hepatol 2005; 42 (Suppl. 2): 79.
  • 10
    Sabbà C, Merkel C, Zoli M, et al. Interobserver and interequipment variability of echo-Doppler examination of the portal vein: effect of a co-operative training program. Hepatology 1995; 21: 42833.
  • 11
    Moriyasu F, Ban N, Nishida O, et al. Clinical application of a ultrasonic duplex system in the quantitative measurement of portal blood flow. J Clin Ultrasound 1986; 14: 57988.
  • 12
    Bolognesi M, Sacerdoti D, Merkel C, Bombonato G, Enzo E, Gatta A. Effects of chronic therapy with nadolol on portal hemodynamics and on splanchnic impedance indices using Doppler sonography: comparison between acute and chronic effects. J Hepatol 1997; 26: 30511.
  • 13
    Merkel C, Bolognesi M, Bellon S, et al. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology 1992; 102: 9739.
  • 14
    Lebrec D. Methods to evaluate portal hypertension. Gastroenterol Clin North Am 1992; 21: 4159.
  • 15
    Lin HC, Tsai YT, Lee FY, et al. Comparison between portal vein pressure and wedged hepatic vein pressure in hepatitis B-related cirrhosis. J Hepatol 1989; 9: 32633.
  • 16
    DeVries PJ, Van Hattum J, Hoekstra JBL, De Hooge P. Duplex Doppler measurements of portal venous flow in normal subjects: inter- and intra-observer variability. J Hepatol 1991; 13: 35863.
  • 17
    Merkel C, Sacerdoti D, Bolognesi M, et al. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone. Hepatology 1997; 26: 349.
  • 18
    Groszmann RJ, Bendtsen F, Bosch J, et al. Baveno II consensus statements: drug therapy for portal hypertension. In: De Franchis, R, ed. Portal Hypertension II. Oxford, UK: Blackwell, 1996: 989.
  • 19
    Grace ND, Groszmann RJ, Garcia-Tsao G, et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 1998; 28: 86880.
  • 20
    de Franchis R, Merkel C, Bolondi L, et al. Committee for Portal Hypertension of the Italian Association for the Study of the Liver. AISF practice guidelines for portal hypertension. Ital J Gastroenterol Hepatol 1999; 31: 22434.
  • 21
    Jalan R, Hayes PC. UK guidelines on the management of variceal haemorrhage in cirrhotic patients (British Society of Gastroenterology). Gut 2000; 46 (Suppl. 3): III1III15.